OB
Ollin Biosciences, Inc.
SEC filingBiotechnology · Austin, TX
Amount raised$156.2Msold at filing
Total offering$330M$173.8M still open
Investors in the raise32count reported to the SEC
FiledJun 24, 2026first sale May 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Travis MurdochDirector
Fred CohenDirector
Alaa HalawaDirector
Cariad ChesterDirector
Jason EhrlichExecutive Officer, Director
Paul BernsDirector
Jason ColomaDirector
Executive officers, directors and promoters as listed on the Form D.